To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNovoBliss Research Pvt Ltd
About this trial
To Check Dermatological Safety of Test Products by 24 Hours Patch Testing
Eligibility criteria
Qualifiers
Age: 18-65 years (both inclusive) at the time of consent.
Sex: Males and non-pregnant/non-lactating females (preferably equal number of males and females).
Subject with normal Fitzpatrick skin type III to V (Human skin colour determination scale).
Females of childbearing potential must have a self-reported negative pregnancy test.
Disqualifiers
Subject having skin irritation, blemishes, excessive hair, moles, pigmentation, pimples, marks (e.g. tattoos (within the previous 3 months), scars, sunburn), open wounds, cuts, abrasions, irritation symptoms or any dermatological condition on the test site(s) i.e. back that can interfere with the reading.
Medication which may affect skin response and/or past medical history.
Subject having history of diabetes
Subject have history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months.
Trial design
Treatments tested in this trial
- 18 Test Products along with positive and negative control
Treatment groups
26 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
NovoBliss Research Pvt Ltd
Lead sponsor
Skin Harmony Lifescience Pvt. Ltd
Collaborator
Source ClinicalTrials.gov